George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDirecta Plus Regulatory News (DCTA)

Share Price Information for Directa Plus (DCTA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.70
Bid: 18.40
Ask: 19.00
Change: 0.00 (0.00%)
Spread: 0.60 (3.261%)
Open: 18.70
High: 18.70
Low: 18.70
Prev. Close: 18.70
DCTA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

First Major Commercial Contract for Gipave

21 Oct 2022 07:00

RNS Number : 6386D
Directa Plus PLC
21 October 2022
 

21 October 2022

 

Directa Plus plc

("Directa Plus" or the "Company")

 

First Major Commercial Contract for Gipave

Italian national motorway to be paved with asphalt enhanced by graphene supermodifier

 

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, announces that an innovative, sustainable, resilient and safe asphalt for the A4 Torino-Milano motorway section, managed by the ASTM Group will be made with G+® graphene and specially selected recycled hard plastics (e.g., toys, fruit crates, litter bins). The asphalt will re-use 70% of milled material from existing pavement, thus reducing the use of new natural aggregates to only 30%. The works will involve both directions for a total of 250 km.

 

The presence of G+® in Gipave® will guarantee greater resistance and mean a longer life span for the road. In addition, the project will deliver significant environmental benefits: energy consumption will be reduced by 90 million kilowatt hours (equivalent to the annual consumption of 30.000 families) and CO2 emissions will be reduced by 18.4 million kilograms (equivalent to the absorption capacity of 115.000 trees).

 

ASTM is an industrial group operating in the sectors of motorway management, large infrastructure engineering and construction projects and transport and mobility technology. The group is the second largest toll road operator in the world with approximately 6,200 km of road managed through concessions in Italy, Brazil and the UK.

 

Gipave® contains the Company's G+® graphene and was developed by Iterchimica with the support of Directa Plus and resulted from a three-year research programme with a patent filed in 2017. The product uses waste plastics that would not normally be recycled and the asphalt containing Gipave® can itself be entirely recycled - promoting the 'circular economy,' which reduces waste and the need for new materials.

 

This commercial contract follows the one kilometre paving of the new Ponte San Giorgio bridge in Genova and a series of demonstration projects to prove the benefits of Gipave®. These have included projects in Italy - airports, and roads - and the UK - re-surfacing of a section of the main road in Curbridge, Oxfordshire, a road section in Dartford, resurfacing trial in Staffordshire and a trial section of a road in Essex. The successful first pilot scheme in Curbridge, Oxfordshire in 2019 showed that Gipave® increases the lifespan of the surface by up to 70 per cent compared to conventional resurfacing methods. The risk of rutting under loads from heavy goods vehicles is also reduced by increased stiffness in the product.

 

Commenting, Giulio Cesareo, Founder and CEO of Directa Plus, said: "Directa Plus has supported partner Iterchimica both in Italy and in the UK from the very beginning of the Gipave® graphene asphalt project.

 

"We are particularly proud to have assisted our partner in the evolution of this application from the trial sections demonstration projects to significant full industrial applications of G+® enhanced asphalt supermodifiers on high mileage motorways, ensuring positive impacts for the environment and local communities. It is a significant validation of our product with no significant impact on 2022 sales but a supply of several tons of material in 2023/2024."

 

 

Federica Giannattasio, CEO Iterchimica, added: "After six years of research and development and numerous trial sections in Italy and abroad that have demonstrated both the technical and environmental performance of this technology, we are extremely proud to contribute together with the ASTM Group to the resurfacing of the A4 Torino-Milano motorway, which will thus become the first hi-tech, safe and sustainable motorway in Europe. The work is being carried out thanks to GiPave's patented technology and our know-how, which we have put at ASTM's disposal to enable the main road link in north-west Italy to achieve this prestigious result. This project, which represents a first step, makes us quite proud and places Italy at the forefront and in line with the ecological transition objectives set out in the UN's 2030 Agenda. The environmental savings are unprecedented, reaching emission reductions of up to 38,5% compared to traditional maintenance technologies. We thank our graphene partner Directa Plus that worked shoulder to shoulder with us since the beginning of this journey "

 

For further information please visit http://www.directa-plus.com/ or contact:

 

Directa Plus plc

+39 02 36714458

Giulio Cesareo, CEO / Giorgio Bonfanti, CFO

Cenkos Securities plc (Nominated Adviser and Joint Broker)

+44 131 220 6939

Neil McDonald / Adam Rae

Singer Capital Markets (Joint Broker)

+44 20 7496 3069

Rick Thompson / Phil Davies

Tavistock (Financial PR and IR)

+44 20 7920 3150

Simon Hudson / Heather Armstrong

 

About Directa Plus

Directa Plus (www.directa-plus.com) is one of the largest producers and suppliers of graphene-based products for use in consumer and industrial markets. The Company's graphene manufacturing capability uses proprietary patented technology based on a plasma super expansion process. Starting from natural graphite, each step of Directa Plus' production process - expansion, exfoliation and drying - creates graphene-based materials and hybrid graphene materials ready for a variety of uses and available in various forms such as powder, liquid and paste.

 

This proprietary production process uses a physical process, rather than a chemical process, to process graphite into pristine graphene nanoplatelets, which enables Directa Plus to offer a sustainable, non-toxic product, without unwanted by-products. Directa Plus' products are made of hybrid graphene materials and graphene nano-platelets. The products (marketed as G+®) have multiple applications due to its properties. These G+® products can be categorised into various families, with different products being suitable for specific practical applications.

 

Directa Plus was established in 2005 and is based in Lomazzo (Como, Italy) and has been listed on the AIM market of the London Stock Exchange since May 2016. The Company holds the Green Economy Mark from London Stock Exchange which recognises companies that contribute to the global green economy.

 

-ends-

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAPPGUAUUPPPUU
Date   Source Headline
15th Apr 20243:01 pmRNSNotification of major holdings
12th Apr 20247:00 amRNSGiPave® installed at Imola Circuit
25th Mar 20247:00 amRNSEUR 1,000,000 Loan Agreement Signed
22nd Mar 20247:00 amRNSCollaboration with UK-based Heathcoat Fabrics
26th Feb 20247:00 amRNSAcquisition of 49% minority interest in Setcar
31st Jan 20247:00 amRNSContract win with FORD Otosan
20th Dec 20237:00 amRNSAcquisition of groundbreaking technology
15th Dec 202311:44 amRNSExpansion of collaboration with Miguel Caballero
10th Nov 20237:00 amRNSChange of Nominated Adviser
27th Sep 20237:00 amRNSHalf-year Report
18th Sep 20237:00 amRNSStrategic collaboration with The SPECTRUM Group
8th Sep 20237:00 amRNSNotice of Interim Results
7th Sep 20237:00 amRNSSignificant contract secured with LIBERTY Galati
19th Jul 20237:00 amRNSProject tender awarded
29th Jun 20237:00 amRNSDirecta Plus receives two new Italian patents
22nd Jun 20237:00 amRNSNew concept for produced water decontamination
15th Jun 20235:40 pmRNSResult of AGM
8th Jun 20237:00 amRNSNew product launch
19th May 20237:00 amRNSPosting of Annual Report and Notice of AGM
10th May 20237:00 amRNSFinal Results
9th May 20237:00 amRNSNew contract with customer Alfredo Grassi
27th Apr 20237:00 amRNSNotice of Results Presentations
20th Mar 20237:00 amRNSNew Patent Granted
27th Feb 20237:00 amRNSTrading Update and Notice of Results
21st Dec 20227:00 amRNSNew significant contract with Pigmentsolution
5th Dec 20222:05 pmRNSSecond Price Monitoring Extn
5th Dec 20222:00 pmRNSPrice Monitoring Extension
2nd Dec 20227:00 amRNSTrading Update
29th Nov 20227:00 amRNSGrant Award
21st Nov 20227:00 amRNSDirectorate Change
28th Oct 20227:00 amRNSFirst Commercial Contract in Latin America
21st Oct 20227:00 amRNSFirst Major Commercial Contract for Gipave
17th Oct 20227:00 amRNSBoar Changes
17th Oct 20227:00 amRNSBoard Changes
29th Sep 202211:05 amRNSSecond Price Monitoring Extn
29th Sep 202211:00 amRNSPrice Monitoring Extension
29th Sep 20227:00 amRNSHalf-year Report
1st Sep 20227:00 amRNSTrading Statement
30th Aug 20227:00 amRNSUS Patent Notice
4th Aug 20227:00 amRNSPartnership Extension and US Patent Award
19th Jul 20227:00 amRNSAgreement with REDA Energy for Grafysorber
5th Jul 20227:00 amRNSSupply Agreement
22nd Jun 20227:00 amRNSGrant of Italian Filtration Patent
17th Jun 20223:40 pmRNSResult of AGM
17th Jun 20227:00 amRNSAGM Statement
19th May 20227:00 amRNSPosting of Annual Report and Notice of AGM
5th May 20227:00 amRNSFinal Results
22nd Apr 20227:00 amRNSPartnership to Develop Automotive Fabrics
4th Apr 20227:00 amRNSUS EPA Authorises Grafysorber for Use in US
7th Mar 20227:00 amRNSOxfordshire Starts Second Trial of GiPave

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.